Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Belviq
Belviq
Key Dates For Arena And Orexigen Investors
Seeking Alpha
Wed, 12/26/12 - 09:34 pm
Orexigen
Contrave
Belviq
Arena Pharmaceuticals
Qsymia
Vivus
obesity
Arena's Marketing Partner Eisai Pharma Seeks Expedited Final Ruling From DEA To Begin Belviq Sales
Seeking Alpha
Mon, 12/24/12 - 10:37 am
Arena
Eisai
Belviq
Investor Enthusiasm Wanes For Obesity Drug Companies
Seeking Alpha
Sun, 12/16/12 - 11:01 am
weight loss
obesity
Arena Pharmaceuticals
Belviq
Vivus
Qsymia
The Looming EU Approval Makes Arena Pharmaceuticals Significantly Undervalued
Motley Fool
Sun, 12/16/12 - 10:18 am
Arena
Belviq
obesity
weight loss
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
Assessing Arena's Belviq As A Diabesity Drug
Seeking Alpha
Wed, 12/12/12 - 10:17 am
Belviq
Arena Pharmaceuticals
obesity
diabetes
Analyst Debate: Is Arena Pharmaceuticals a Top Stock?
Motley Fool
Sat, 12/8/12 - 11:01 am
Arena Pharmaceuticals
Belviq
weight loss
obesity
1 Deal Arena Investors Might Have Missed
Motley Fool
Sun, 12/2/12 - 11:52 am
Arena Pharmaceuticals
Belviq
weight loss
obesity
Picking The Weight Loss Winner In The Arena Vs. Vivus War
Seeking Alpha
Mon, 11/19/12 - 11:16 am
Arena Pharmaceuticals
Vivus
Belviq
Qsymia
Arena Pharmaceuticals Outlines Its Path To Profitability
Seeking Alpha
Fri, 11/16/12 - 10:41 am
Arena Pharmaceuticals
Belviq
Vivus’ Problems are Arena's Opportunities
Motley Fool
Fri, 11/16/12 - 10:33 am
Vivus
Arena Pharmaceuticals
obesity
Qsymia
Belviq
Are Arena and VIVUS Frenemies?
Motley Fool
Thu, 11/15/12 - 04:36 pm
Arena Pharmaceuticals
Vivus
Qsymia
Belviq
obesity
A Realistic View Of Belviq In The Short Term
Seeking Alpha
Wed, 11/14/12 - 12:26 pm
Belviq
obesity
Arena Pharmaceuticals
Down 20%: What Is VIVUS' Market Opportunity?
Motley Fool
Tue, 11/6/12 - 12:21 pm
Vivus
obesity
Qsymia
Belviq
Arena Pharmaceuticals' Solution to a Billion Dollar a Day Problem
Motley Fool
Mon, 11/5/12 - 11:15 am
Arena Pharmaceuticals
obesity
Belviq
Arena Looks To Be The Clear Winner In The Weight Loss Space
Seeking Alpha
Sun, 11/4/12 - 10:27 am
Arena Pharmaceuticals
Vivus
Qsymia
weight loss
obesity
Belviq
Why Arena's Launch Will Be Strong, Despite Vivus' Weak Launch
Motley Fool
Thu, 11/1/12 - 06:09 pm
Arena Pharmaceuticals
obesity
Vivus
Belviq
Qsymia
What Does This Rejection Mean for Obesity Drugmakers?
Motley Fool
Sat, 10/20/12 - 10:36 am
Vivus
Qsymia
obesity
weight loss
Belviq
Arena Pharmaceuticals
3 Reasons Why Eisai Should Purchase Arena Pharmaceuticals
Motley Fool
Wed, 10/17/12 - 11:51 am
Arena Pharmaceuticals
Eisai
Belviq
3 Interesting Moves In Biotech Stocks From Wednesday
Seeking Alpha
Thu, 10/4/12 - 10:58 am
Sarepta
Amarin
Arena Pharmaceuticals
Belviq
Vascepa
eteplirsen
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
next ›
last »